Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the usual study record content and navigation and making the trial details inaccessible.SummaryDifference18%

- Check35 days agoChange DetectedRevision label on the page updated from v3.6.5 to v3.6.6, indicating a software version increment. No study content changes are reflected in the provided data.SummaryDifference0.0%

- Check42 days agoChange DetectedA new NIH funding reference line, '2015 ( U.S. NIH Grant/Contract )', was added to the Study ID Numbers section to indicate the grant source for the study.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a new build/version of the site content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, signaling an update to the page metadata.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page shows revision v3.6.3, indicating a minor backend or template update. There are no substantive changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.